Quality of Life and Mental Health in Children and Adolescents
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00159601|
Recruitment Status : Completed
First Posted : September 12, 2005
Last Update Posted : April 4, 2017
|Condition or disease|
|Psychiatric Diagnosis Mental Disorders|
Measuring and monitoring Quality of Life in children and youths continues to increase in importance to both researchers and decision makers. Only a limited number of well validated instruments that measure Quality of Life in children exists, and in Norway only few has been translated into Norwegian. Up to date there are no studies investigating the quality of Life in Norwegian child and adolescent psychiatric patients in a longitudinal perspective, compared to the normal population.
Two generic Quality of Life instruments (KINDL, Bullinger & Ravens-Sieberer 2000 and the ILC, Matejatt & Remschmidt 1998) are introduced in Norway by this study in addition to the use of other well established measures like the "Child behaviour Check List" (Achenbach et al. 2001), etc.
Comparisons: 400 patients and their parents in a child psychiatric outpatient clinic 2000 pupils from the normal population in the middle of Norway Repeated measures after 6 months in both groups. In addition a follow up study for the clinical group 3 years after referral started in june 2006.
|Study Type :||Observational|
|Actual Enrollment :||2342 participants|
|Official Title:||Quality of Life and Mental Health in Children and Adolescents in a Child and Adolescent Psychiatric Outpatient Clinic and in the Normal Population|
|Actual Study Start Date :||June 2003|
|Actual Primary Completion Date :||December 2008|
|Actual Study Completion Date :||December 2008|
|outpatients in Child and Adolescent Mental Health Service|
|youth from general population|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00159601
|NTNU Norwegian University of Science and Technology|
|Trondheim, Norway, NO-7489|
|Principal Investigator:||Thomas Jozefiak, M.D.||NTNU Norwegian University of Science and Technology|